Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis
Clinical trial NCT00878072 · COMPLETED
Trial details
- NCT number
- NCT00878072
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-25
- Primary completion
- 2010-06-02
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.